Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan

• Главные авторы: Akemi Egami (Автор), Shinji Takahashi (Автор), Takeshi Kokubo (Автор), Sreedevi Boggarapu (Автор), Eric Beresford (Автор)
• Формат: ‌
• Опубликовано: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Introduction Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder affecting several organs, including skin. We sought to assess the real-world effectiveness and safety of a topical sirolimus 0.2% gel treatment for TSC-related cutaneous manifestations. Methods We co...